Hypertension and Inflammation in Alzheimer's Disease: Close Partners in Disease Development and Progression!

Paul Gard, Lucy Nelson, Naji Tabet

Research output: Contribution to journalArticle

Abstract

Alzheimer's disease (AD) is by far the most common sporadic neurodegenerative disorder. Clinically it is associated with cognitive and other neuropsychological impairments, and neuropathologically it is distinguished by presence of amyloid- plaques and neurofibrillary tangles. Hypertension has been traditionally associated with the etiology of vascular dementia, however, vascular risk factors including hypertension are increasingly being implicated in AD. Likewise, the importance of neuroinflammation in AD pathogenesis is also widely recognized. Data from animal and non-AD human studies suggest a close reciprocal relationship between hypertension and inflammatory systems. Much less is known on the potential pathological interaction between hypertension and inflammation inADand its subsequent effects on amyloid and tau misfolding, aggregation, and propagation, events recognized as critical for the development and progression of AD. This review summarizes what is known about the mechanistic interactions between hypertension and inflammatory mediators and assesses their potential synergistic/additive role in AD genesis. Increasing our understanding of the pathological interactions between the recognized risk factors for AD is a worthwhile endeavor in a condition which currently has limited treatment options but an increasing number of potential preventative measures.
Original languageEnglish
Pages (from-to)331-343
Number of pages13
JournalJournal of Alzheimers Disease
Volume41
Issue number2
DOIs
Publication statusPublished - 31 Dec 2014

Fingerprint

Disease Progression
Alzheimer Disease
Hypertension
Inflammation
Animal Diseases
Neurofibrillary Tangles
Vascular Dementia
Amyloid Plaques
Amyloid
Neurodegenerative Diseases

Keywords

  • Alzheimer's disease
  • amyloid
  • cerebrovasculature
  • dementia
  • hypertension
  • inflammation

Cite this

@article{8771c9ce766449ed924d05875c3f5bd4,
title = "Hypertension and Inflammation in Alzheimer's Disease: Close Partners in Disease Development and Progression!",
abstract = "Alzheimer's disease (AD) is by far the most common sporadic neurodegenerative disorder. Clinically it is associated with cognitive and other neuropsychological impairments, and neuropathologically it is distinguished by presence of amyloid- plaques and neurofibrillary tangles. Hypertension has been traditionally associated with the etiology of vascular dementia, however, vascular risk factors including hypertension are increasingly being implicated in AD. Likewise, the importance of neuroinflammation in AD pathogenesis is also widely recognized. Data from animal and non-AD human studies suggest a close reciprocal relationship between hypertension and inflammatory systems. Much less is known on the potential pathological interaction between hypertension and inflammation inADand its subsequent effects on amyloid and tau misfolding, aggregation, and propagation, events recognized as critical for the development and progression of AD. This review summarizes what is known about the mechanistic interactions between hypertension and inflammatory mediators and assesses their potential synergistic/additive role in AD genesis. Increasing our understanding of the pathological interactions between the recognized risk factors for AD is a worthwhile endeavor in a condition which currently has limited treatment options but an increasing number of potential preventative measures.",
keywords = "Alzheimer's disease, amyloid, cerebrovasculature, dementia, hypertension, inflammation",
author = "Paul Gard and Lucy Nelson and Naji Tabet",
year = "2014",
month = "12",
day = "31",
doi = "10.3233/JAD-140024",
language = "English",
volume = "41",
pages = "331--343",
journal = "Journal of Alzheimers Disease",
issn = "1387-2877",
number = "2",

}

Hypertension and Inflammation in Alzheimer's Disease: Close Partners in Disease Development and Progression! / Gard, Paul; Nelson, Lucy; Tabet, Naji.

In: Journal of Alzheimers Disease, Vol. 41, No. 2, 31.12.2014, p. 331-343.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hypertension and Inflammation in Alzheimer's Disease: Close Partners in Disease Development and Progression!

AU - Gard, Paul

AU - Nelson, Lucy

AU - Tabet, Naji

PY - 2014/12/31

Y1 - 2014/12/31

N2 - Alzheimer's disease (AD) is by far the most common sporadic neurodegenerative disorder. Clinically it is associated with cognitive and other neuropsychological impairments, and neuropathologically it is distinguished by presence of amyloid- plaques and neurofibrillary tangles. Hypertension has been traditionally associated with the etiology of vascular dementia, however, vascular risk factors including hypertension are increasingly being implicated in AD. Likewise, the importance of neuroinflammation in AD pathogenesis is also widely recognized. Data from animal and non-AD human studies suggest a close reciprocal relationship between hypertension and inflammatory systems. Much less is known on the potential pathological interaction between hypertension and inflammation inADand its subsequent effects on amyloid and tau misfolding, aggregation, and propagation, events recognized as critical for the development and progression of AD. This review summarizes what is known about the mechanistic interactions between hypertension and inflammatory mediators and assesses their potential synergistic/additive role in AD genesis. Increasing our understanding of the pathological interactions between the recognized risk factors for AD is a worthwhile endeavor in a condition which currently has limited treatment options but an increasing number of potential preventative measures.

AB - Alzheimer's disease (AD) is by far the most common sporadic neurodegenerative disorder. Clinically it is associated with cognitive and other neuropsychological impairments, and neuropathologically it is distinguished by presence of amyloid- plaques and neurofibrillary tangles. Hypertension has been traditionally associated with the etiology of vascular dementia, however, vascular risk factors including hypertension are increasingly being implicated in AD. Likewise, the importance of neuroinflammation in AD pathogenesis is also widely recognized. Data from animal and non-AD human studies suggest a close reciprocal relationship between hypertension and inflammatory systems. Much less is known on the potential pathological interaction between hypertension and inflammation inADand its subsequent effects on amyloid and tau misfolding, aggregation, and propagation, events recognized as critical for the development and progression of AD. This review summarizes what is known about the mechanistic interactions between hypertension and inflammatory mediators and assesses their potential synergistic/additive role in AD genesis. Increasing our understanding of the pathological interactions between the recognized risk factors for AD is a worthwhile endeavor in a condition which currently has limited treatment options but an increasing number of potential preventative measures.

KW - Alzheimer's disease

KW - amyloid

KW - cerebrovasculature

KW - dementia

KW - hypertension

KW - inflammation

U2 - 10.3233/JAD-140024

DO - 10.3233/JAD-140024

M3 - Article

VL - 41

SP - 331

EP - 343

JO - Journal of Alzheimers Disease

JF - Journal of Alzheimers Disease

SN - 1387-2877

IS - 2

ER -